ATE490331T1 - Pseudotransposons und rekombinante hyperaktive transpositionssysteme, abgeleitet vom mos-1- transposon - Google Patents

Pseudotransposons und rekombinante hyperaktive transpositionssysteme, abgeleitet vom mos-1- transposon

Info

Publication number
ATE490331T1
ATE490331T1 AT07731461T AT07731461T ATE490331T1 AT E490331 T1 ATE490331 T1 AT E490331T1 AT 07731461 T AT07731461 T AT 07731461T AT 07731461 T AT07731461 T AT 07731461T AT E490331 T1 ATE490331 T1 AT E490331T1
Authority
AT
Austria
Prior art keywords
mos
hyperactive
transposon
nucleotide sequence
recombinant
Prior art date
Application number
AT07731461T
Other languages
English (en)
Inventor
Sylvie Bigot
Yves Bigot
Florence Bonnin-Rouleux
Stephanie Germon
Gwenhael Jegot
Original Assignee
Centre Nat Rech Scient
Univ Francois Rabelais De Tours
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Francois Rabelais De Tours filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE490331T1 publication Critical patent/ATE490331T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Insects & Arthropods (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07731461T 2006-05-15 2007-05-15 Pseudotransposons und rekombinante hyperaktive transpositionssysteme, abgeleitet vom mos-1- transposon ATE490331T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604285A FR2900935A1 (fr) 2006-05-15 2006-05-15 Systemes de transposition recombinants hyperactifs derives du transposon mos-1
PCT/FR2007/000823 WO2007132096A2 (fr) 2006-05-15 2007-05-15 Systemes de transposition recombinants hyperactifs derives du transposon mos-1

Publications (1)

Publication Number Publication Date
ATE490331T1 true ATE490331T1 (de) 2010-12-15

Family

ID=37836760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731461T ATE490331T1 (de) 2006-05-15 2007-05-15 Pseudotransposons und rekombinante hyperaktive transpositionssysteme, abgeleitet vom mos-1- transposon

Country Status (9)

Country Link
US (1) US20100291682A1 (de)
EP (1) EP2021485B1 (de)
JP (1) JP2009537130A (de)
AT (1) ATE490331T1 (de)
CA (1) CA2651413A1 (de)
DE (1) DE602007010921D1 (de)
ES (1) ES2374418T3 (de)
FR (1) FR2900935A1 (de)
WO (1) WO2007132096A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090042297A1 (en) * 2007-06-01 2009-02-12 George Jr Alfred L Piggybac transposon-based vectors and methods of nucleic acid integration
EP3628732B1 (de) * 2014-11-05 2023-05-03 Illumina, Inc. Transposasezusammensetzungen zur verringerung von insertionsbias
CN110468188B (zh) * 2019-08-22 2023-08-22 广州微远医疗器械有限公司 用于二代测序的标签序列集及其设计方法和应用
CN114317584B (zh) * 2021-11-23 2023-06-23 海南医学院 新型转座子突变株文库的构建系统、新型转座子突变文库和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319168A1 (en) * 1999-10-01 2001-04-01 The Board Of Trustees Of The University Of Illinois Hyperactive mutants of himar1 transposase and methods for using the same
FR2850395B1 (fr) * 2003-01-28 2007-12-14 Centre Nat Rech Scient Transposases d'elements genetiques mobiles mariner mutantes, non phosphorylables et hyperactives

Also Published As

Publication number Publication date
EP2021485B1 (de) 2010-12-01
US20100291682A1 (en) 2010-11-18
WO2007132096A3 (fr) 2008-02-14
ES2374418T3 (es) 2012-02-16
DE602007010921D1 (de) 2011-01-13
FR2900935A1 (fr) 2007-11-16
EP2021485A2 (de) 2009-02-11
CA2651413A1 (fr) 2007-11-22
WO2007132096A2 (fr) 2007-11-22
JP2009537130A (ja) 2009-10-29

Similar Documents

Publication Publication Date Title
ATE514783T1 (de) Plasmidsystem zur expression mehrerer gene
NO20082783L (no) Induserbare ekspresjonssystemer
DK2074143T3 (da) Ændrede antistoffer
CY1113199T1 (el) Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης
JO2778B1 (en) Certain Compounds, Compositions and Methods
SG10201408300PA (en) Processing of amplified dna fragments for sequencing
EP4105644A3 (de) Systeme und vorrichtungen zur "sequence-by-synthesis"-analyse
NO20075471L (no) Betjening av en eller flere drivstoffautomater
AU2009236219A8 (en) Silencing of CSN5 gene expression using interfering RNA
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
WO2008069906A3 (en) Digital expression of gene analysis
PH12019502238A1 (en) Systems and methods for use in identifying multiple genome edits and predicting the aggregate effects of the identified genome edits
WO2005007869A3 (en) Assays for the direct measurement of gene dosage
DK2089516T3 (da) Fremgangsmåder til at forbedre indføringen af DNA i bakterielle celler
LT2012062A (lt) Kompozicijos, būdai ir susiję panaudojimai, skirti modifikuotos dnr skaldymui
DE602005013272D1 (de) Diphenyl-substituierte alkane als flap-inhibitoren
ATE490331T1 (de) Pseudotransposons und rekombinante hyperaktive transpositionssysteme, abgeleitet vom mos-1- transposon
NO20050051D0 (no) Fremgangsmate og system for autentiseringsinformasjon matet inn i datamaskinsystemer
MX2008013397A (es) Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos.
ATE532861T1 (de) Expressionsvektor
ATE465406T1 (de) Vorzeitig alternde mäuse zur demonstration der rolle der dna-schädigung bei der alterung und eingriff in die altersbedingte pathologie
WO2010042685A3 (en) Inhibitors of the atb(0,+) transporter and uses thereof
DE502005002856D1 (de) Einrichtung zur Behandlung von Informationsträgern
MX383565B (es) Proteinas derivadas de genes cry de bacillus thuringiensis.
MX2007011411A (es) Interaccion rage/diaphanous y composiciones relacionadas y metodos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties